Abstract
Just 3 years after being purchased from AkzoNobel by the investment firms the Carlyle Group and GIC for $11.6 billion, Nouryon has announced plans to offer shares on the New York Stock Exchange. The Dutch specialty chemical maker has yet to disclose the number of shares or the planned price per share. The firm intends to use money from the share offering to pay down debt and meet other corporate requirements. Nouryon’s annual sales will be about $4.5 billion after the spin-off of its base-chemical unit.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
